The project aims for the development of a new legume variety that will bring agronomic sustainability and gives the starting material for a new and healthy bakery and feed products.
Doxebo is a liposomal formulation jointly invented by the israeli and hungarian applicants. It reduces the risk of serious, occasionally lethal adverse effect of doxil and other similar nano-drugs. In this application we propose preclinical studies necessary for regulatory approval of doxebo.
The mission of the consortium is to utilize state-of-the-art pharmaceutical approaches and develop tnf-alpha-binding protein-imprinted polymers for the specific elimination of tnf-alpha from the gastrointestinal tract hence improving the therapy of currently untreatable crohn's disease.
The project aims at the development of software support for mrgfus treatments of prostate cancer comprising 3d visualization, interactive treatment planning, and automatic mr image quality assurance.